国家财富与微创胸外科手术的全球推广:欧洲胸外科医师学会数据库的洞察
结果显示开胸率显著下降(P < .001),VATS(P < .001)和RATS(P = .0049)使用率上升;VATS adoption 与人均GDP负相关(p = .00022),RATS无显著相关(p = .68)。结论认为经济因素促进技术初期扩散,但系统与制度变量决定高级平台的 uptake。
要点
- 开胸率显著下降,VATS和RATS使用率随时间上升。
- VATS adoption 与人均GDP负相关,RATS无显著相关。
- 国家间差异显著,法国和意大利 adoption 较高,中等收入国家较慢。
核心结论
- 人均GDP显著影响VATS的 adoption,但不影响RATS,表明经济因素促进技术初期扩散,而系统与制度变量决定高级平台的 uptake。
主要发现
- 开胸率随时间显著下降(P < .001),VATS(p < .001)和RATS(p = .0049) adoption 增加。
- VATS adoption 与人均GDP负相关(p = .00022),RATS adoption 无显著相关(p = .68)。
- 楔形切除与VATS adoption 增加相关(p < .001),新辅助治疗负相关(p < .001)。
- 国家层面变异显著(p < .001),法国和意大利 adoption 较高,土耳其等中等收入国家 uptake 较慢。
- GDP与国家 adoption 呈非线性相关(p = .0036),医院层面差异极小(p = .78)。
临床怎么用
- 关注经济因素对VATS推广的影响,同时重视卫生技术评估、报销和采购框架等制度变量对RATS uptake 的作用。
- 需协调加强基础设施、培训和政策框架,以解决微创胸外科手术可及性差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The global adoption of minimally invasive thoracic surgical techniques, including robotic-assisted thoracic surgery (RATS) and video-assisted thoracic surgery (VATS), has significantly reduced surgical trauma and enhanced recovery. However, adoption rates vary widely across countries, influenced by economic, clinical, and systemic factors. This study examines the influence of national wealth, as measured by the gross domestic product (GDP) per capita, on the adoption of these techniques using data from the European Society of Thoracic Surgeons Database. METHODS: A retrospective analysis of 148 628 lung operations (2001-2023) was conducted, integrating clinical data with GDP per capita from the World Bank. Generalized linear mixed models were used to assess the relationships between GDP and adoption rates, while adjusting for patient- and institution-level factors. RESULTS: Thoracotomy rates have declined significantly over time (P < .001), while the adoption of VATS (p < .001) and RATS (p = .0049) has increased. VATS adoption was negatively associated with GDP per capita (p = .00022), whereas RATS adoption showed no significant correlation (p = .68). More straightforward procedures, such as wedge resections, were correlated with increased adoption of VATS (p < .001), whereas neoadjuvant therapy was negatively associated (p < .001). Country-level variability was significant (p < .001), with higher adoption rates in France and Italy and slower uptake in middle-income countries such as Turkey. GDP exhibited a nonlinear correlation with country adoption (p = .0036), whereas hospital-level differences were minimal (p = .78). CONCLUSIONS: National wealth, as measured by GDP per capita, significantly influences the adoption of VATS but not RATS, indicating that, whereas economic factors facilitate the initial diffusion of technology, other systemic and institutional variables, such as health technology assessment, reimbursement, and procurement frameworks, govern the uptake of more advanced platforms. Addressing disparities in access to minimally invasive thoracic surgery requires coordinated efforts to strengthen infrastructure, training, and policy frameworks. Scientific societies could play a pivotal role in promoting the equitable dissemination and implementation of these innovations across diverse health-care systems.
引用
- Bertolaccini L, Ciani O, Pericchi Marrero LM, et al. National Wealth and the Global Spread of Minimally Invasive Thoracic Surgery: Insights from the European Society of Thoracic Surgeons Database. Eur J Cardiothorac Surg. 2025. PMID: 41206066. doi:10.1093/ejcts/ezaf384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。